[go: up one dir, main page]

NO321401B1 - Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav - Google Patents

Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav Download PDF

Info

Publication number
NO321401B1
NO321401B1 NO20004822A NO20004822A NO321401B1 NO 321401 B1 NO321401 B1 NO 321401B1 NO 20004822 A NO20004822 A NO 20004822A NO 20004822 A NO20004822 A NO 20004822A NO 321401 B1 NO321401 B1 NO 321401B1
Authority
NO
Norway
Prior art keywords
dispersion medium
active substance
suspension
weight
pharmaceutical composition
Prior art date
Application number
NO20004822A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004822L (no
NO20004822D0 (no
Inventor
Dietrich Tuerck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20004822D0 publication Critical patent/NO20004822D0/no
Publication of NO20004822L publication Critical patent/NO20004822L/no
Publication of NO321401B1 publication Critical patent/NO321401B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20004822A 1998-03-27 2000-09-26 Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav NO321401B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (de) 1998-03-27 1998-03-27 Perorale Wirkstoff-Suspension
PCT/EP1999/001948 WO1999049845A1 (de) 1998-03-27 1999-03-23 Perorale wirkstoff-suspension

Publications (3)

Publication Number Publication Date
NO20004822D0 NO20004822D0 (no) 2000-09-26
NO20004822L NO20004822L (no) 2000-11-23
NO321401B1 true NO321401B1 (no) 2006-05-08

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004822A NO321401B1 (no) 1998-03-27 2000-09-26 Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav

Country Status (25)

Country Link
EP (2) EP0945131A1 (pt)
JP (1) JP3323189B2 (pt)
KR (1) KR100587208B1 (pt)
CN (1) CN1150888C (pt)
AR (1) AR016196A1 (pt)
AT (1) ATE225648T1 (pt)
AU (1) AU762464B2 (pt)
BR (1) BR9909189A (pt)
CA (1) CA2326048C (pt)
CO (1) CO5070601A1 (pt)
DE (1) DE59903023D1 (pt)
DK (1) DK1066029T3 (pt)
ES (1) ES2184428T3 (pt)
HU (1) HU228474B1 (pt)
IL (1) IL137479A (pt)
MY (1) MY124599A (pt)
NO (1) NO321401B1 (pt)
NZ (1) NZ507610A (pt)
PL (1) PL192969B1 (pt)
PT (1) PT1066029E (pt)
TR (1) TR200002772T2 (pt)
TW (1) TWI232759B (pt)
UY (1) UY25443A1 (pt)
WO (1) WO1999049845A1 (pt)
ZA (1) ZA200003951B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
ZA200508653B (en) * 2003-04-07 2007-03-28 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
DE602005009016D1 (de) * 2004-12-06 2008-09-25 Janssen Pharmaceutica Nv Orale suspension mit meloxicam
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
MX389960B (es) * 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
EP2544660B1 (en) * 2010-03-10 2018-06-13 Lupin Limited Rifaximin ready-to-use suspension
NZ712826A (en) * 2010-03-19 2017-03-31 Boston Biomedical Inc Novel compounds and compositions for targeting cancer stem cells
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
EP2937640A4 (en) * 2012-12-19 2016-08-17 Mitsubishi Electric Corp AIR CONDITIONING
CA2982836A1 (en) 2015-04-28 2016-11-03 Mars, Incorporated Process of preparing a sterilized wet pet food product
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
CN112044605B (zh) * 2019-06-06 2022-06-21 钟志勇 选钛药剂及选钛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
CO5070601A1 (es) 2001-08-28
HUP0102036A2 (hu) 2002-03-28
TWI232759B (en) 2005-05-21
EP1066029B1 (de) 2002-10-09
JP2002509875A (ja) 2002-04-02
WO1999049845A1 (de) 1999-10-07
UY25443A1 (es) 1999-11-17
AU762464B2 (en) 2003-06-26
KR20010042197A (ko) 2001-05-25
EP0945131A1 (de) 1999-09-29
BR9909189A (pt) 2000-12-05
CN1295462A (zh) 2001-05-16
ES2184428T3 (es) 2003-04-01
DE59903023D1 (en) 2002-11-14
ZA200003951B (en) 2002-01-18
PL342345A1 (en) 2001-06-04
CA2326048A1 (en) 1999-10-07
NO20004822L (no) 2000-11-23
CA2326048C (en) 2008-08-12
NZ507610A (en) 2003-08-29
HK1034184A1 (en) 2001-10-19
PT1066029E (pt) 2003-02-28
HUP0102036A3 (en) 2002-12-28
EP1066029A1 (de) 2001-01-10
HU228474B1 (en) 2013-03-28
IL137479A (en) 2005-09-25
CN1150888C (zh) 2004-05-26
KR100587208B1 (ko) 2006-06-08
IL137479A0 (en) 2001-07-24
JP3323189B2 (ja) 2002-09-09
AU3147099A (en) 1999-10-18
MY124599A (en) 2006-06-30
AR016196A1 (es) 2001-06-20
ATE225648T1 (de) 2002-10-15
TR200002772T2 (tr) 2000-12-21
DK1066029T3 (da) 2003-01-27
PL192969B1 (pl) 2006-12-29
NO20004822D0 (no) 2000-09-26

Similar Documents

Publication Publication Date Title
US6184220B1 (en) Oral suspension of pharmaceutical substance
NO321401B1 (no) Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav
ES2310653T3 (es) Procedimiento para preparar una composicion farmaceutica finamente autoemulsionable.
CA2567075C (en) Pharmaceutical suspension composition
EA007901B1 (ru) Стабилизированная суспензионная лекарственная форма для перорального применения
US9649318B2 (en) Formulation of meloxicam
ES2335622T3 (es) Suspension acuosa estable con buen gusto.
US8999395B2 (en) Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
TW200914028A (en) Pirenoxine contented two liquid applying eye drop medicine
BRPI0715756B1 (pt) Composição farmacêutica para administração oral, seus usos, e medicamento
TWI707684B (zh) 點眼用懸濁製劑
MXPA00007809A (en) Peroral active agent suspension
HK1034184B (en) Peroral active agent suspension
WO2008098586A1 (en) Pharmaceutical carrier composition and pharmaceutical composition
JP2001294528A (ja) アシクロビル懸濁シロップ剤
CN111989101A (zh) 具有受控溶出的水性悬浮液型药物制剂
EP2558079A1 (en) Ciprofloxacin dry syrup composition
HK40044257A (en) Aqueous suspension-type pharmaceutical preparation having controlled dissolution
JP2002187840A (ja) 分岐鎖アミノ酸を含有する医薬用懸濁剤
HK1172252A (en) Pharmaceutical suspension composition
HK1233540B (zh) 眼用混悬液制剂

Legal Events

Date Code Title Description
MK1K Patent expired